KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

American Well (AMWL) Research & Development (2019 - 2026)

American Well has reported Research & Development over the past 7 years, most recently at $13.9 million for Q4 2025.

  • For Q4 2025, Research & Development fell 25.78% year-over-year to $13.9 million; the TTM value through Dec 2025 reached $72.9 million, down 15.34%, while the annual FY2025 figure was $72.9 million, 15.34% down from the prior year.
  • Research & Development for Q4 2025 was $13.9 million at American Well, down from $18.6 million in the prior quarter.
  • Over five years, Research & Development peaked at $37.5 million in Q1 2022 and troughed at $13.9 million in Q4 2025.
  • A 5-year average of $25.5 million and a median of $25.9 million in 2023 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: surged 65.64% in 2022 and later crashed 30.84% in 2023.
  • Year by year, Research & Development stood at $33.8 million in 2021, then dropped by 18.04% to $27.7 million in 2022, then dropped by 4.83% to $26.3 million in 2023, then fell by 28.71% to $18.8 million in 2024, then decreased by 25.78% to $13.9 million in 2025.
  • Business Quant data shows Research & Development for AMWL at $13.9 million in Q4 2025, $18.6 million in Q3 2025, and $18.2 million in Q2 2025.